Video Shorts

What Drives New Excipient Development?
0:29
What Drives New Excipient Development?
3 months ago
by
David Schoneker(+1 more)
Richard Sanderson, IPS
0:47
The Synergy Between Lean Production & Sustainability
3 months ago
by
Richard Sanderson(+1 more)
Leslie Weaver, IPS
0:27
The Best Way to Integrate Susatainability
3 months ago
by
Leslie Weaver(+1 more)
George Hunt, IPS
0:35
When to Think About Lean Production
3 months ago
by
George Hunt(+1 more)
Bryan Poltilove
0:16
Cutting Carbon Footprints by Two-Thirds
3 months ago
by
Bryan Poltilove
Ryan Kelly, Rx-360
0:42
Closing the Quality-Supply Chain Gap
3 months ago
by
Ryan Kelly(+1 more)
Avi Nandi, SK Pharmteco
0:45
Cell & Gene Therapy Supply Chain Challenges, Explained
3 months ago
by
Avi Nandi(+1 more)
George Kwiecinski
0:35
Are FDA Foreign Inspections Working?
3 months ago
by
George Kwiecinski
Maria Batalha, Valgenesis
0:42
Centralizing Drug Substance Data With AI-Enabled Analytics
3 months ago
by
Maria Batalha(+1 more)
Why Zero Complaints Is a Bad Sign
0:20
Why Zero Complaints Is a Bad Sign
3 months ago
by
Siegfried Schmitt(+1 more)
Devices Must Work for Everyone
0:20
Devices Must Work for Everyone
3 months ago
by
Siegfried Schmitt(+1 more)
David Chau
0:16
Enthusiasm Surrounding Continuous Bioprocessing
3 months ago
by
David Chau
Bethany Silva
0:30
The Future Is Here for Pharma
3 months ago
by
Bethany Silva
Bryan Poltilove
0:38
The Industry Inflection Point: Why the Future Is Bright
3 months ago
by
Bryan Poltilove
Christa Myers
0:39
Panel on What Robotics in Aseptic Means for Operations Teams - Key Takeaway
3 months ago
by
Christa Myers
Todd Vaughn
0:59
The Biggest Takeaway on Robotics in Aseptic
3 months ago
by
Todd Vaughn
Why CDMOs Must Stay Close to Industry Trends
0:20
Why CDMOs Must Stay Close to Industry Trends
3 months ago
by
Ranjit Deshmukh(+1 more)
Why Truly 'Novel' Excipients Are So Rare
0:14
Why Truly 'Novel' Excipients Are So Rare
3 months ago
by
David Schoneker(+1 more)
Standardizing Processes for Faster Turnarounds
0:20
Standardizing Processes for Faster Turnarounds
3 months ago
by
Ranjit Deshmukh(+1 more)
Why Most New Excipients Fail to Market
0:24
Why Most New Excipients Fail to Market
3 months ago
by
David Schoneker(+1 more)
Steven Falcone, Novo Nordisk
0:59
Automated Quality Inspections Explained
3 months ago
by
Steven Falcone(+2 more)
Christopher Lewis, Emoja Biopharma
0:57
How AI Can Enhance Training
3 months ago
by
Christopher Lewis(+1 more)
Steven Falcone, Novo Nordisk
0:45
How Big Pharma Addresses Regulatory Gaps On Multiple Sites
3 months ago
by
Steven Falcone(+2 more)
Christopher Lewis, Emoja Biopharma
0:36
The Essentials for AI Risk Management
4 months ago
by
Christopher Lewis(+1 more)
Susan Schniepp, Regulatory Compliance Associates Inc
0:22
Can AI Release Pharmaceutical Batches?
4 months ago
by
Susan J. Schniepp(+2 more)
Susan Schniepp, Regulatory Compliance Associates Inc
0:28
How AI Handles Data Integrity
4 months ago
by
Susan J. Schniepp(+2 more)
Susan Schniepp, Regulatory Compliance Associates Inc
0:39
Small Companies Should Stop Mimicking Big Pharma
4 months ago
by
Susan J. Schniepp(+2 more)
Susan Schniepp, Regulatory Compliance Associates Inc
0:41
When Do You Tweak a Method Out of Compliance?
4 months ago
by
Susan J. Schniepp(+2 more)
Susan Schniepp, Regulatory Compliance Associates Inc
0:35
Why Quality Systems Are Worth The Investment
4 months ago
by
Susan J. Schniepp(+2 more)
Eli Lilly's $2.75B AI Move
0:15
Eli Lilly's $2.75B AI Move
4 months ago
by
Susan Haigney